HomeHealthCholesterol drug pelacarsen fails to prevent heart attacks in major trial

Cholesterol drug pelacarsen fails to prevent heart attacks in major trial

November 8, 2026

An experimental drug that held great promise in driving down a dangerous form of cholesterol didn’t show any measurable impact on heart attack or stroke in a clinical trial.

Read the full story at NBC News »

Pelacarsen, a promising drug for an inherited heart risk, flops, stunning doctors

info@sportsmedical.news

Most Popular

Cholesterol drug pelacarsen fails to prevent heart attacks in major trial

Pelacarsen, a promising drug for an inherited heart risk, flops, stunning doctors

Energy drinks linked to heart attacks in young adults in new AHA study findings

The flu strain driving this season’s unusually early spread

Most Popular

Pelacarsen, a promising drug for an inherited heart risk, flops, stunning doctors

Energy drinks linked to heart attacks in young adults in new AHA study findings

No one knew why a dad couldn’t eat. Then a surgeon took a second look.

Caffeine and pre-workout supplements tied to heart attack risk, study finds

Recent Comments

Links

Contact Us

Join Our Team